Recurrent Respiratory Papillomatosis — Bevacizumab for Treatment of Recurrent Respiratory Papillomatosis (RRP)
Citation(s)
A Pilot Study to Evaluate the Effects of Antiangiogenic Factor as an Adjunct Treatment After Photoangiolysis in Patients With Bilateral Recurrent Respiratory Papillomatosis of the Vocal Fold